Centric Wealth Management Maia Biotechnology, Inc. Transaction History
Centric Wealth Management
- $357 Million
- Q1 2025
A detailed history of Centric Wealth Management transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Centric Wealth Management holds 68,248 shares of MAIA stock, worth $113,974. This represents 0.03% of its overall portfolio holdings.
Number of Shares
68,248
Previous 68,219
0.04%
Holding current value
$113,974
Previous $134,000
22.39%
% of portfolio
0.03%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding MAIA
# of Institutions
21Shares Held
1.23MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA650KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$358,1090.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$131,1300.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA55.1KShares$92,0170.0% of portfolio
-
State Street Corp Boston, MA53.3KShares$88,9270.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $18.3M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...